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Abbreviations 
ALPPS: Associating Liver Partition and Portal vein ligation for Staged hepatectomy 
FLR: Future liver remnant 
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Zusammenfassung 
Einleitung: Die Leber ist das einzige Organ, was nach der Resektion eines Anteiles, z.B. 
wegen eines Lebertumors, zur Regeneration fähig ist. Bei der einzeitigen Leberresektion 
(PHx) wird die erkrankte Leber vollständig entfernt. Dementsprechend ist die 70%-ige 
Resektion im Kleintier das am häufigsten verwendete experimentelle Modell zur 
Untersuchung der resektionsinduzierten Leberregeneration. Ist das onkologisch erforderliche 
Resektionsausmaß so groß, daß die künftige Restleber zu klein für den Patienten ist, wird das 
zweizeitige Verfahren angewendet. Bei dem zweizeitigen Verfahren wird im ersten Schritt 
eine Pfortaderokklusion des tumortragenden Leberlappens durchgeführt. Die 
Pfortaderokklusion führt zur Atrophie des portaldeprivierten Lappens und damit zur 
Hypertrophie der zukünftigen Restleber. Im zweiten Schritt wird der atrophierte 
tumortragende Leberanteil entfernt. Häufig wird im ersten Operationsschritt zusätzlich zur 
Pfortaderligatur (PVL) eine atypische Resektion durchgeführt. In dieser Situation wirken zwei 
Stimuli gleichzeitig auf den deportalisierten Leberlappen. Es ist jedoch unbekannt, wie der 
deportalisierte Leberlappen auf den gleichzeitig applizierten Regenerationsreiz antwortet; wie 
also der Leberlappen im Falle von gegensätzlich wirkenden Stimuli seine Größe reguliert. 
Deshalb ist ein besseres Verständnis der regulatorischen Prozesse erforderlich, um den 
Prozess der Größenregulation potenziell an die Bedürfnisse der Patienten anzupassen zu 
können. 
Ziel: Das Ziel dieser Arbeit ist die Untersuchung der intrahepatischen Größenregulation. 
Zwei Faktoren, die die intrahepatischen Größenregulation beeinflussen, wurden untersucht: 
der Effekt der interlobären Kollateralbildung zwischen portalisierter und deportalisierter 
Leber und die Wirkung gegensätzlicher, aber gleichzeitig applizierter Stimuli wie der PVL 
und der PHx, die auf die deportalisierte Leber einwirken. 
Methoden und Ergebnisse: Um ein geeignetes experimentelles System zur Untersuchung 
dieser spezifischen wissenschaftlichen Fragen zu identifizieren, evaluierten wir die 
beschriebenen Tiermodelle und verschafften uns einen Überblick über die aktuellen 
Techniken zur Untersuchung der Leberregeneration. Zusammen mit unseren 
Kooperationspartnern erarbeiteten wir einen Ablauf zur Generierung und Analyse von 
computertomographischen Schnittbildern um das lebervenöse System und die 
Kollateralbildung zu visualisieren. 
Um den Effekt der interlobären Kollateralbildung auf die intrahepatische Größenregulation zu 
untersuchen, entwickelten wir ein „Associating Liver Partition and Portal Vein Ligation for 
Staged Hepatectomy“ (ALPPS) –Modell in der Ratte. Das chirurgische Modell besteht aus 
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einer erweiterten PVL und der Transektion  des medianen Leberlappens vor der 
nachfolgenden Leberresektion. Die Resektionsflächen wurden durch die Platzierung einer 
mechanischen Barriere zwischen den zwei getrennten Lappen separiert, um eine 
Kollateralbildung zu verhindern. Wir bestätigten, dass die Verhinderung der 
Kollateralbildung die Hypertrophie des künftigen Restleberlappens beschleunigte, und die 
Atrophie des deportalisierten Leberlappens steigerte. 
Um die Wirkung der gegensätzlichen, aber gleichzeitig auf die deportalisierte Leber 
einwirkenden Stimulus zu untersuchen, haben wir ein weiteres chirurgisches Modell etabliert. 
Wir kombinierten eine kleine 20%-ige PVL mit einer großen 70%-igen PHx. Trotz des 
fehlende portalen Zustrom verhinderte der PHx-vermittelte Regenerationsstimulus die 
Atrophie des deportalisierten Leberlappens durch Induktion der Hepatozytenproliferation. Der 
portal deprivierte Leberlappen nahm an Größe zu. 
Um die Balance zwischen unterschiedlichen starken Regenerations- und Atrophiestimuli  zu 
untersuchen, etablierten wir ein weiteres chirurgisches Modell, bestehend aus einer großen 
70%-igen PVL und einer kleinen 20%-iger PHx. Der PHx-induzierte Regenerationsstimulus 
hemmte die Atrophie des deportalisierten Leberlappens durch Herunterregulierung der 
hepatischen Apoptose. Es zeigte sich ein inverser Zusammenhang der Apoptoserate mit der 
Stärke des Regenerationsstimulus: ein großer Resektionsreiz(70%PHx) war mit einer 
geringen Apoptoserate assoziiert, ein kleiner Resektionreiz(20%PHx) war mit einer höheren 
Apoptoserate assoziiert, jedoch niedriger als nach alleiniger PVL. In dieser Situation (kleiner 
Resektionsreiz und großer Atrophiereiz) trug möglicherweise die Bildung extrahepatischer 
porto-portaler Kollateralen aufgrund der inkompletten portalen Deprivation zur Hemmung der 
Apoptose und damit zu der niedrigen Apoptoserate bei.  
Zusammenfassung: Die Ausbildung porto-portaler Kollateralen reduziert das Ausmaß an 
Atrophie nach PVL. Wir konnten erstmalig zeigen, dass die Einwirkung gegensätzlicher 
Stimuli auf den portal deprivierten Leberlappen (simultaner PHx und PV) gleichzeitig zur 
Proliferation und zur Apoptose von Hepatozyten im diesem Leberlappen führt.  
Leberregeneration und hepatische Hypertrophie können also trotz portaler Deprivation 
induziert werden. Das Ausmaß der gleichzeitig durchgeführten Resektion bestimmt die 
Apoptoserate und damit maßgeblich die Größe des portal deprivierten Leberlappens. 
Diese Ergebnisse stellen die weitverbreitete Annahme in Frage, dass der portale Fluss eine 
wesentliche Rolle bei der Leberregeneration spielt. Als nächster Schritt müssen die 
molekularen Mechanismen der intrahepatischen Größenregulation weiter untersucht werden. 
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Summary 
Background: The liver is the only organ that can regenerate after partial surgical removal, e.g. 
because of a tumor. In the one-stage procedure, major partial hepatectomy (PHx) is performed 
to remove the diseased liver completely. Accordingly, the rodent model of 70%PHx is the 
most frequently used experimental model to study resection-induced liver regeneration. Once 
the oncological requirement of liver mass resection is so large that the future remnant liver is 
too small for the patient, a two-stage procedure is performed. The two-stage procedure 
consists of portal vein occlusion of the tumor-bearing liver lobe as first step prior to resecting 
this lobe in the second step. Portal vein occlusion induces atrophy of the deportalized liver 
lobes and hypertrophy of the future remnant liver. Frequently, atypical resection is performed 
in addition to portal vein ligation (PVL) in the first stage operation. In this situation, two 
concurrent stimuli act on the deportalized liver lobe. However, it is not well explored how the 
liver governs intrahepatic size regulation, especially how the deportalized liver may respond 
to the concurrent stimuli. Therefore, better understanding of the underlying regulatory 
processes is needed to potentially modulate the size adaption process according to the need of 
the patient.  
 
Aim: We put our emphasis on exploring intrahepatic size regulation. Two factors accounting 
for intrahepatic size regulation were investigated: the effect of inter-lobar collateral formation 
between portalized and deportalized liver and the effect of a simultaneous regeneration 
signals imposed on the deportalized liver.   
 
Methods and results: To identify an adequate model for the specific scientific questions, we 
evaluated the existing models and gained an overview about current techniques for studying 
liver regeneration. We established a CT-based image acquisition and analysis work flow with 
our cooperation partners to visualize the hepatic venous system and the formation of 
collaterals.  
 
To explore the effect of inter-lobar collateral formation on intrahepatic size regulation, we 
developed an “Associating Liver Partition and Portal vein ligation for Staged hepatectomy” 
(ALPPS) model consisting of major PVL and median lobe transection. Liver transection was 
secured by placing a mechanical barrier between the two divided lobes to prevent formation 
of collateral. We confirmed that prevention of collateral formation accelerated hypertrophy of 
the future remnant liver lobes and augmented atrophy of the deportalized liver lobes.  
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To investigate the effect of a simultaneous regeneration stimulus acting on the deportalized 
liver lobe, we developed a novel surgical model consisting of the combination of 20%PVL 
and 70%PHx. We observed that the PHx-induced regeneration signals prevented atrophy of 
the deportalized liver lobe by inducing hepatocyte proliferation despite the lack of portal 
supply. Actually the deportalized liver lobe increased in size. 
To investigate the effect of the balance between regeneration stimulus and atrophy stimulus 
on the deportalized liver, we further evaluated the intrahepatic size regulation using a model 
of 70%PVL and 20%PHx. We learned that the PHx-induced regeneration stimulus inhibited 
atrophy of the deportalized liver lobe by down-regulation of hepatic apoptosis, which was 
inversely correlated to the strength of the regeneration stimulus: a major resection stimulus 
was associated with a low apoptotic rate; a minor resection stimulus was associated with a 
higher apoptotic rate, although lower than the apoptotic rate after PVL only. In case of minor 
PHx and major PVL, the formation of porto-portal collaterals probably contributed to the less 
pronounced apoptotic rate because of the incomplete portal deprivation. 
 
Conclusions: The formation of porto-portal collaterals decreased the extent of atrophy after 
PVL. We demonstrated for the first time that hepatocyte proliferation and apoptosis can be 
induced in the same liver lobe despite portal deprivation. This observation challenges the 
widespread assumption of the essential role of portal flow in liver regeneration. As a next step, 
the underlying molecular mechanisms governing the intrahepatic size regulation need to be 
further explored.  
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 Introduction 
The liver plays an important role in many bodily functions spanning from protein synthesis   
and glucose metabolism to excretion of waste products and detoxification. The liver is the 
only organ with the capacity to regenerate after death of parenchymal cells or surgical loss of 
parenchymal mass. The earliest description of liver regeneration can be found in myths from 
ancient Greece--the well-known legend of “Prometheus”. His liver was partly eaten by an 
eagle during the day and grew back over night so that Prometheus had to suffer the 
punishment over and over (Hesiod's Theogony, circa 700 B.C.). The liver recovery after 
partly loss was called “regeneration”. 
Liver regeneration is needed to compensate for loss of hepatocytes.  Loss of hepatocytes 
may occur due to intoxication, viral infection, and inflammatory processes or due to hepatic 
surgery.  Liver regeneration is playing a crucial role in restoring the number of hepatocytes 
lost due to such liver injuries. These injuries can directly cause cell damage by inducing 
dysfunction of cell membranes, interfering with gene expression and protein synthesis or 
inflammatory reactions.  
The surgically most important loss of hepatocytes occurs upon liver resection. The commonly 
studied rodent model of liver resection– 70% partial hepatectomy (PHx), was firstly 
introduced by Higgins and Anderson in 1931 (Higgins 1931). The liver underwent 
compensatory hypertrophy after the removal of liver lobes. The model is still widely used 
nowadays.  In clinical settings, liver resection is mainly performed in oncological surgery to 
remove primary or secondary liver tumors (Glantzounis et al. 2016, Giglio et al. 2016, 
Hayashi et al. 2007). After liver resection, the portal flow (per unit liver mass) increases 
instantly. This hyperperfusion initiates the release of various molecular signals such as 
cytokines (tumor necrosis factor alpha, interleukin 6) and growth factors (hepatocyte growth 
factor, epidermal growth factor), resulting in hepatocyte mitosis and proliferation. 
Liver regeneration leads to a restoration of liver mass within weeks.  In the 70%PHx 
model in rodents, three of the five liver lobes are surgically removed without causing damage 
to the remnant two lobes. The remnant liver lobes undergo hypertrophy until the original liver 
weight is restored. This process takes 5-7 days in small animals such as rats and mice. In 
humans, normal liver weight is reestablished within 8-15 days (Michalopoulos 2007).  
Small and moderate liver resections are well tolerated by the healthy organ without 
concurrent hepatic disease. However, extended liver resection puts the patient at risk due to an 
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insufficient mass of the future liver remnant (FLR). The size of the FLR represents the major 
limitation when planning extended liver resections.  
Great efforts in surgical research were placed on developing strategies to accelerate liver 
regeneration. The key strategy to enhance the size of the FLR is portal vein occlusion. The 
occlusion of a portal vein induces atrophy of the occluded liver lobe carrying the tumor, while 
the non-occluded liver lobe undergoes compensatory hypertrophy by liver regeneration 
(Dimitroulis et al. 2014, Makuuchi et al. 1990). Therefore, portal vein occlusion is widely 
adopted to enlarge the FLR before extended liver resection (Abdalla et al. 2002).  
However, in about 20% of the cases, this strategy fails to achieve curative resection because 
of tumor progress or insufficient liver regeneration after portal vein occlusion (Lam et al. 
2013, Abulkhir et al. 2008). Tumor progress usually occurs in the waiting period (1-3 months) 
prior to extended liver resection (Hoekstra et al. 2012, Hayashi et al. 2007, Mailey et al. 2009). 
Insufficient liver regeneration may have several reasons: insufficient size or impaired tissue 
quality of the FLR and collateral formation between the ligated and the non-ligated liver 
lobe (Riehle et al. 2011, Stavrou et al. 2012, Wilms et al. 2008).  
Limited size of FLR is impairing liver regeneration. There are reports indicating that 
experimental 90%hepatectomy is mostly fatal (Asencio et al. 2014). It is also well-known that 
the marginal mass in orthotopic split liver transplantation causes so-called “small for size 
syndrome” (Dahm et al. 2005, Serenari et al. 2013). The limited size of FLR is presenting a 
high risk of acute liver failure after operation. It is well known that portal hyperperfusion to 
the FLR induces severe shear stress in the hepatic sinusoids, which causes damage to 
sinusoidal endothelial cells and subsequently impairs liver regeneration (Schleimer et al. 2006, 
Xu et al. 2006).  
Impaired tissue quality subsequent to preexistent damage of the liver such as hepatic 
steatosis, fibrosis, cirrhosis, cholestasis, or damage due to a previous chemotherapy is 
increasing the risk of insufficient liver regeneration (de Graaf et al. 2009). Therefore a larger 
future remnant liver mass is required after liver injury compared to healthy liver tissue.  
Collateral formation between deprived liver and non-deprived liver was discovered in cases 
with limited hypertrophy in FLR (van Lienden et al. 2013, Denys et al. 1999). During waiting 
period after PVL perfusion of the ligated portal veins was observed. This revealed 
intrahepatic collateral connections between the non-ligated left portal branches and the ligated 
right branches. This collateral formation was taken as one reason for this limited hypertrophy. 
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Additional evidence for this view was gained from the observation that an increase in FRL 
volume was achieved after complete secondary portal vein embolization (PVE).  
Accordingly, Schnitzbauer et al. developed a novel surgical technique so called “associating 
liver partition and portal vein ligation for staged hepatectomy” (ALPPS)  to prevent formation 
of porto-portal collaterals between the FLR and the liver to be resected (Schnitzbauer et al. 
2012). The key procedure is liver transection followed by a major PVL of the liver to be 
resected. Although the procedure is unequivocally of great challenge and carries a certain 
surgical risk, it is efficient to accelerate liver regeneration of the FLR.  
Liver size recovery is due to liver regeneration. After PHx, hypertrophy of remnant liver is 
due to liver regeneration. It is well known, that regeneration is due to proliferation of 
hepatocytes and non-parenchymal cells (Michalopoulos 2007, Michalopoulos und DeFrances 
1997, Fausto et al. 2006). Once the necessary liver mass size/liver function has been restored, 
liver regeneration is terminated. After PVL, size increase of contralateral liver lobe and 
atrophy of deportalized liver lobe occurs. Evidence was also accumulated that hepatic atrophy 
of portally deprived liver is due to necrosis and apoptosis (Mueller et al. 2003). However, the 
extent of hepatic atrophy and hypertrophy cannot be reliably predicted. This also leads to an 
interest in the interaction of liver regeneration and hepatic atrophy.  
Recently, some studies focused on intrahepatic size regulation in terms of liver regeneration 
and hepatic atrophy. The balance between hepatocyte proliferation and apoptosis in 
considered critical for liver homeostasis (Zhou et al. 2015). However, the investigation 
regarding regulatory processes is limited to the situation of PVL, and the investigations of 
size regulation are limited to either liver regeneration or lobular atrophy.  
It has not been reported   how contradictory stimuli govern intrahepatic size regulation in case 
of simultaneous PVL and PHx. Further research is needed to better understand the regulatory 
processes. Understanding is not only scientifically interesting, but also important to better 
modulate liver regeneration to the need of the patients.  
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Aims 
We wanted to better understand intrahepatic liver size regulation after liver resection and 
portal vein ligation in this study. Therefore, we set three goals: 
1. Establish an ALPPS model to explore the role of collateral formation in intrahepatic 
size regulation;  
2. Investigate intrahepatic size regulation in case of concurrent stimuli in a novel 
surgical model; 
3. Assess the balance of liver regeneration and hepatic atrophy governing the 
intrahepatic size regulation. 
For each aim we proposed a hypothesis to be tested in the study. 
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Hypotheses 
1. Transsection of hepatic parenchyma prevents collateral formation and enhances hepatic 
regeneration. 
2. Hepatic atrophy of deportalized liver lobe after PVL can be prevented by a simultaneously 
applied regeneration stimulus induced by concurrent PHx. 
3. Intrahepatic size regulation is governed by the balance of regeneration and atrophy stimuli 
in case of opposing simultaneously applied stimuli.  
 If regeneration stimulus is larger than atrophy stimulus on a given lobe, a size increase 
of the liver lobe is induced (RS>AS results in size increase);  
 If regeneration stimulus is smaller than atrophy stimulus on a given lobe, a size 
decrease of the liver lobe is induced (RS<AS results in size decrease). 
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Study design 
1. To better understand liver regeneration, a literature work up spanning over the past 
decades was required. The current knowledge about liver regeneration in animal 
models was summarized. Special emphasis was put on rodent models and 
techniques for assessment of liver regeneration up to date. A review paper entitled 
“Models and Techniques of Studying Liver Regeneration” was generated (Wei W, 
et al, Eur Surg Res 2015). 
2. To investigate the effect of hepatic transection on collateral formation, intrahepatic 
vascular anatomy was visualized and a novel ALPPS model established. This 
model was used to assess intrahepatic size regulation.  A paper entitled 
“Establishment of a Rat Model: Associating Liver Partition with Portal Vein 
Ligation for Staged Hepatectomy” was published (Wei W, et al, Surgery 2016). 
3. To explore intrahepatic size regulation in case of concurrent PHx and PVL, the 
individual size regulation of each lobe in a surgical model of right PVL+70%PHx 
was studied. Individual liver size adaptation and the hepatic proliferation index 
were evaluated. In this experiment, the portal hyper perfusion was also assessed. 
The manuscript entitled “Intrahepatic size regulation in a surgical model: “Liver 
resection induced-liver regeneration” counteracts the local atrophy following 
simultaneous portal vein ligation” was published (Wei W, et al, Eur Surg Res 
2016) 
4. To expand investigation of intrahepatic size regulation, concurrent PHx and PVL 
of varying extent were combined. The effects of balance between regeneration 
and atrophy were elucidated by assessing liver size regulation in terms of 
proliferation index and apoptosis index in different models of concurrent PVL and 
PHx. The corresponding manuscript entitled “The regenerative stimulus in the 
deportalized liver determines hepatic apoptosis to govern the extent of hepatic 
atrophy” is submitted to “British Journal of Surgery” (Wei W, et al, Br J Surg. 
Under review). 
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Abstract 
Background: Portal vein ligation (PVL) and atypical resection are usually performed as a 
first operation of two-stage hepatectomy to cure liver tumors. A large number of patients fail 
to undergo sufficient hypertrophy of the unligated regenerating lobe and atrophy of the 
deportalized lobe. However, the role of the additional resection in this complex process of 
intrahepatic size regulation remains unclear. This study aims for investigating the effects of 
the additional partial hepatectomy (PHx) on size regulation of the deportalized liver lobe 
when performing simultaneous PVL+PHx. 
Methods: Lewis-rats were subjected  to either 20%,70% or 90%PHx respectively PVL as 
control or to a combined procedure consisting of 20%PVL+70%PHx respectively 
70%PVL+20%PHx. Relative weights of liver lobes, proliferation index (PI) and apoptotic 
density were assessed. Explanted livers were subjected to computer-tomography to 
investigate formation of collaterals. 
Results: After the combined procedure, size of non-ligated liver increased 4-fold(maximal 
PI>15%). Size of the ligated lobe increased to140% after small ligation+large resection but 
decreased to75% after large ligation+small resection, whereas maximal PI was similarly low 
(6.3% versus 3.6%). However, apoptotic density in the portally-deprived lobes was related to 
the extent of PHx (3cells/mm
2
 after 20%PVL+70%PHx compared to14cells/mm
2
 after 
70%PVL+20%PHx). Here, size regulation was associated with formation of extrahepatic 
collaterals as also observed after 90%PVL, where size reduction and apoptotic density was 
less pronounced than after 20% or 70%PVL. 
Conclusions: The additional liver resection seemed to counteract the local atrophy in a PHx-
extent-dependent way by suppressing hepatic apoptosis, possibly facilitated by the 
reestablishment of extrahepatic porto-portal collaterals.  
Keywords: intrahepatic size regulation, portal vein ligation, partial hepatectomy, hepatocyte 
proliferation, apoptosis  
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Summary for surgical relevance  
 
Portal vein ligation (PVL) with simultaneous atypical resection was adopted in selected 
patients with primarily non-resectable liver tumors. Better understanding of intrahepatic size 
regulation in case of concurrent PVL and liver resection may help to develop clinical 
strategies of promoting liver regeneration and avoiding postoperative liver failure.  
Our study indicated that interaction of proliferation and apoptosis seemed to regulate the 
intrahepatic size adjustment. Simultaneous liver resection is not only inducing hepatocyte 
proliferation in the ligated lobe but also suppressing hepatic apoptosis remarkably leading to a 
less pronounced atrophy of deportalized lobe. Furthermore, liver regeneration was enhanced 
after PVL and simultaneous liver resection compared to an extended PVL only. 
These observations support that an atypical resection combined with moderate portal vein 
ligation leads to better tolerance of the liver to extended hepatectomy in comparison to a 
single major PVL. This could serve as an additional argument of removing more tumor-
bearing liver in the first stage-operation. 
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Introduction: 
Liver resection is the best curative strategy to treat liver tumors and metastases
1, 2
. Loss of 
liver mass due to partial hepatectomy (PHx) is compensated by the regenerative capacity of 
remnant liver to restore liver volume and function. However, extended hepatectomy may 
result in insufficient future liver remnant mass, associated with hepatic dysfunction and acute 
postoperative liver failure. To reduce the risk of fulminant liver failure, portal vein ligation 
(PVL) of the diseased liver has been established as one optional strategy. After PVL, the 
portally-supplied future remnant liver lobes undergo compensatory hypertrophy
3
, which 
significantly improves the tolerance to extended hepatectomy
4
. However, the extent of 
hypertrophy seems to be unpredictable.  Previous reports
5, 6
 demonstrated that about one third 
of patients undergoing portal vein occlusion do not proceed to liver resection, mostly due to 
insufficient liver regeneration.  
Insufficient liver regeneration may have several reasons: insufficient size or impaired tissue 
quality of the future remnant liver and collateral formation between the ligated and the non-
ligated liver
7, 8
. The formation of interlobe porto-portal neocollaterals after PVL was 
postulated to reduce the extent of atrophy in the portally-deprived lobe and to reduce the 
hypertrophy in the portally-supplied lobe
9, 10 . This leads to an interest in the interaction of 
liver regeneration and hepatic atrophy.  
Recently, some studies focused on liver regeneration not only in terms of proliferation but 
also in terms of apoptosis. Zhou
11
 reported that the balance between hepatocyte proliferation 
and apoptosis is critical for liver homeostasis during liver regeneration. Köhler
12
 investigated 
hepatocytes proliferation and apoptosis after PHx to assess liver regeneration. It is not clear 
how the contradictory processes govern the intrahepatic size regulation. Further studies are 
needed to better understand the regulatory processes. Understanding is not only scientifically 
interesting, but also important to better modulate liver regeneration to the need of the patient.  
We observed previously that loss of liver mass due to PHx represents a proliferation stimulus 
not only to the portally-supplied lobe but also to the portally-deprived lobe
13
. We questioned 
to which extent the additional PHx might exert a regenerative effect on the portally-deprived 
lobe. To investigate this question, we extended our previous study of concurrent PVL and 
PHx. We designed an experiment to elucidate the effects of two concurrent stimuli of 
different extent on the size regulation of the portally-deprived lobe. Furthermore, explanted 
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livers injected with contrast polymer were subjected to computer-tomography imaging to 
investigate collateral formation. 
Methods:  
Animals 
Animal experiments were performed in inbred male Lewis Rats (Charles River, Sulzfeld, 
Germany) aged 9-10 weeks (body weight 250-300g). Rats were fed a laboratory diet with 
water and rat chow ad libitum until harvest and were kept under constant environmental 
conditions with a 12h light–dark cycle in a conventional animal facility until harvest.  
Ethics statement 
All procedures and housing of the animals were performed according to current German 
regulations and guidelines for animal welfare and the ARRIVE Guidelines for Reporting 
Animal Research 
14
. The Thüringer Landesamt für Verbraucherschutz, Thuringia, Germany 
approved the protocols (Approval-Number: 02-024/13). 
Experimental design 
Seventy-two male Lewis rats were enrolled randomly into 3 groups with partial hepatectomy 
(PHx). Liver resections of different extent (20%PHx, 70%PHx and 90%PHx) were performed 
to determine the strength of regenerative stimulus on the size regulation of the remnant liver. 
Another 72 rats were subjected to 20%PVL, 70%PVL and 90%PVL to determine the 
correlation between the extent of ligation and atrophy. Additional 48 rats were allocated into 
two groups to further investigate the effect of the two concurrent stimuli on the size regulation: 
(i) 20%PVL+70%PHx: ligation of right portal vein in combination with resection of left lateral 
and median lobes; (ii) 70%PVL+20%PHx: ligation of left portal vein in combination with liver 
resection of right lobe (Supplemental Figure 1).  
Operative procedures and postoperative management  
Surgical procedures were performed under inhalation of 3% isoﬂurane mixed with pure 
oxygen at a flow rate of 0.5L/min (isoflurane vaporizer, Sigma Delta, UK). Laparotomy was 
carried out via a transverse upper abdominal incision. PHx was performed using a modified 
technique from the precise vessel-oriented technique
15
. The portal vein, hepatic artery and bile 
duct of the respective lobe were ligated before resection to minimize the proliferation of the 
ischemic tissue in the stump. Resection of right lobe represented removal of 20% of the liver 
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mass, resection of left lateral lobe and median lobe represented 70%PHx. Both together 
represented 90%PHx.  PVL was performed carefully under an operating microscope (Zeiss, 
magnification 10-25×, Germany). Ligation of right portal vein represented 20%PVL; ligation 
of left portal vein represented 70%PVL, while ligation of both right and left portal vein 
represented 90%PVL. All animals received analgesic treatment with buprenorphine in a dose 
of 0.05 mg/kg body weight (Temgesic, Essex Pharma GmbH, Germany).  Daily assessment of 
activity was carried out. Animals in each group were harvested at four observation time points 
(postoperative day (POD) 1, 2, 3 and 7, n=6/group/time points). One hour before harvest, 5-
bromo-2-deoxyuridine (BrdU, SIGMA-ALDRICH, St. Louis, USA) was injected via penile 
vein in a dose of 50 mg/kg body weight for revealing hepatocellular proliferation. 
Liver enzymes  
Blood was collected for measurement of serum aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) by using the AEROSET System (Abbott Laboratories, Wiesbaden, 
Germany) according to the instructions of the manufacturers. 
Liver explantation, liver weight determination  
Livers were mobilized for liver explantation and photodocumentation (Supplemental Figure 
2). Individual liver lobes were weighed to calculate the liver weight/body weight ratio using 
the following formula: liver weight of individual lobe (g)/ body weight (g)*100%. Six 
additional rats were subjected to laparotomy to obtain normal values of liver weights and 
normal range of liver enzymes.  
Immunohistochemistry (IHC) 
Liver sections were cut after formalin fixation and paraffin embedding. BrdU-staining was 
performed using a monoclonal anti-BrdU antibody (Dako, Hamburg, Germany) following the 
protocol described previously
16
. The terminal deoxynucleotidyltransferase-mediated UTP end 
labeling (TUNEL) staining was performed using an Apoptag peroxidase in-situ apoptosis-
detection kit (Intergen, Purchase, NY) according to the manufacturer’s instructions.  
Assessment of proliferation and apoptosis 
The analysis of proliferation index (PI) was performed with a histological image analysis tool 
“Histokat” ( Fraunhofer MEVIS, Bremen, Germany) as described previously13. The result was 
expressed as the fraction of proliferating hepatocyte nuclei to the total number of hepatocyte 
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nuclei (accurate to 0.1%). In contrast , apoptosis density was assessed manually  by counting 
the number of TUNEL-positive cells per observation area (magnification 400-fold) in 10 
fields per animal (given as cells/mm
2
)
17
. PI was defined as high when it was more than 20%; 
PI was defined as moderate when it was less than 20% but more than 10%; PI was defined as 
low when it was less than 10%. 
Visualization of portal blood supply 
Additional 11 rats were subjected to portal vascular anatomy study using imaging technique. 
The portal blood supply of the remnant liver was visualized using an imaging approach before 
(n=1) as well as immediately and 7 days after operation (N=10). The imaging work flow 
followed the same protocol as described before
18
. Briefly, contrasting the vascular tree was 
achieved by injecting a silicone radiopaque contrast agent (Microfil; Flow Tech, Inc., Carver, 
Mass., USA) into the portal vein. Subsequently, the explanted liver were subjected to 
formalin fixation, and the specimens were scanned using the scan protocol HQD-6565-390-90 
during one full rotation with a scanning time of 90s per subscan (TomoScope Duo CT; CT 
Imaging GmbH, Erlangen, Germany). Three-dimensional reconstruction of the vascular tree 
was performed using “Imalytics Preclinical” (Philips Research, Aachen, Germany). 
Statistical analysis 
The data, expressed as mean ±standard deviation (SD), were analyzed using SigmaPlot 13.0 
(Statcon, Witzenhausen, Germany). Differences between paired groups were analyzed using 
the two-tailed paired samples Student’s t-test and multiple groups were compared using the 
one way independent ANOVA test. Differences were considered statistically significant if p-
values were less than 0.050. 
Results:  
Combination of small and moderate PVL and PHx caused less liver damage than 
extended 90%PHx. 
All animals tolerated the surgical procedure well in respect to the severity of surgical stress 
(See Supplemental Table 1, displaying the levels of liver enzymes in relation to the surgical 
procedure). As expected, a small 20% PVL caused minor hepatic injury defined as ALT<250 
IU/L and AST<500IU/L. In contrast, removal of 20% of the liver mass respectively ligating 
70% or 90% of the liver mass caused moderate liver injury (250IU/L<ALT<750IU/L and 
500IU/L<AST<1000IU/L). Removing 70% or 90% of the liver mass caused major hepatic 
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injury (ALT>750IU/L, AST>1000IU/L). In the combination groups the extent of resection 
determined the severity of the procedure.   Irrespectively of the surgical procedure, animals 
experienced maximal hepatic damage on POD 1 which recovered within 7 days.  
Total liver weight recovery time correlated to the extent of PHx. 
Partial hepatectomy: Total remnant liver weight and its recovery time correlated with the 
extent of PHx (Figure 1A). The total liver/body weight ratio was 3.3% in unresected control 
animals. The remnant liver started to regain its weight from POD 1. Total liver weight 
recovered fully within 7 days after 20%PHx (vs. control, p=0.390) and almost fully after 
70%PHx (vs. control, p =0.019).  In contrast 90%PHx, total liver weight did not recover fully 
comparing with the control liver weight after 7 days (vs. control, p<0.001).  
Portal vein ligation: Total liver weight was maintained after 20% and 70%PVL by the timely 
balance of hepatic atrophy and hypertrophy, but not after 90%PVL. After 90%PVL, the total 
liver weight to body weight ratio decreased during the first 3 postoperative days, but 
recovered within 7 days (Figure 1B).  In this case, the ligated liver mass underwent severe 
atrophy at a faster pace than the regeneration of the small non-ligated lobe, leading to a 
decrease of relative total liver weight during three postoperative days.  
Combination group: Total liver weight and its recovery correlated to the extent of PHx 
(Figure 1C). The recovery was slower comparing with the recovery after PHx only. This 
finding is in line with the transient loss of liver mass observed after 90%PVL. 
The ligated liver lobes adjusted their size according to extent of PHx.  
Portal vein ligation: The relative weight of ligated lobes decreased comparably to about 1/3 
of the original liver weight after 20%PVL and 70%PVL only (see Figure 2A). In contrast, 
after 90%PVL atrophy was less pronounced. Atrophy of the left and median lobe reached 46% 
of the original liver whereas the right liver lobe only lost very little of its mass reaching 95% 
of the original liver weight (p<0.001).  
Combination group: In contrast, the ligated right lobe in 20%PVL+70%PHx group did not 
decrease in weight, but increased steadily to almost 140% of the starting weight on POD 7 
(see also previous study
13
) , which was significantly higher than the 95% relative liver weight 
observed  after 90%PVL (p<0.001) (Figure 2A). In contrast, in case of 70%PVL+20%PHx, 
the relative weight of ligated left lateral lobe (LLL) and median lobe (ML) only decreased 
to 75% of the original value on POD 7, which was significantly less than the decrease to 46% 
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observed in the 90%PVL (p<0.001) (Figure 2B). Therefore it seems that the weight 
adaptation of the ligated lobes may be related to the extent of resection: with a large resection 
leading to an overall increase in liver weight and a small resection leading to an overall 
decrease in liver weight, but less pronounced than after ligation only.  
Hepatocyte proliferation in the ligated lobe was induced in case of additional PHx. 
Partial hepatectomy: Hepatocyte proliferation occurred after hepatectomy and was related to 
the extent of liver resection (Figure 3A). The PI reached its peak on POD 1 with a maximum 
of 3%, 25% and 28% after 20%PHx, 70%PHx and 90%PHx respectively. 
Portal vein ligation: As expected, the PI of the non-ligated caudate lobe was related to the 
extent of ligation (Figure 3B). 20%PVL only induced a maximal PI of 2%, whereas 70%PVL 
induced a maximal PI of 8% and 90%PVL induced an even higher PI of 12.2%. Only few 
proliferating hepatocyte were observed in the ligated lobe after PVL only, irrespectively of 
the extent of ligation (Figure 3D).  
Combination group: In the non-ligated caudate lobe, moderate PI (about15%) without a 
defined peak was observed on POD 1 and POD 2 (Figure 3C). There was no significant 
difference of PI in the non-ligated lobes between the two combination groups (p>0.050). 
However, the PI was significantly higher on POD 2 and POD 3 after additional PHx than after 
90%PVL only (p<0.001), accompanied by an enhanced liver weight recovery of the non-
ligated caudate lobe on POD 7 (p=0.001and p=0.035) (Supplemental Figure 3).  
Hepatocyte proliferation did occur also in the ligated lobes after additional liver resection 
with the peak on POD 2 (PI of 6.3% and 3.6% respectively) (Figure 3D, F). Notably, the PI 
of ligated lobes in both combination groups were more than 10-fold higher comparing with PI 
in PVL only groups (PI of 0.3%, p<0.001). Both observations together confirmed the 
induction of a proliferative response in the ligated lobes in case of the additional resection.   
Apoptosis density in the ligated lobe was remarkably reduced in case of additional PHx. 
Partial hepatectomy: Apoptosis was not observed after hepatectomy only (data not shown).  
Portal vein ligation: Apoptosis was observed in the deportalized lobes after PVL only and 
reached a maximum on POD3. The apoptotic density was not clearly related to the extent of 
ligation. High apoptotic density (>26 cells/mm²) was observed in the right lobe after 20%PVL 
and on LLL after 70%PVL. However, 90%PVL resulted in a significantly lower apoptotic 
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density (3cells/mm
2
 in RL and 14 cells/mm² in LLL, p<0.001) (Figure 4A, B, C). Rare single 
apoptotic cells were also observed in the non-ligated lobes (data not shown). 
Combination group: Interestingly, we observed a reduced apoptotic density with a maximum 
on POD 3 on the ligated liver lobes. Reduction of apoptosis was very pronounced in right 
lobe after 20%PVL+70%PHx and  reached only a maximum of 3 cells/mm², significantly 
lower comparing with 20%PVL group (27 cells/mm
2
; p<0.001) (Figure 4A, C).Similarly, 
reduction of apoptosis was also observed, but less pronounced in LLL after 
70%PVL+20%PHx (14 cells/mm²), significantly lower comparing with 70%PVL group (31 
cells/mm
2
; p<0.001) (Figure 4B, C).  
Taken together, the size increase or decrease of the portally-ligated lobe after the combined 
procedure seemed to be related to the extent of the additional liver resection. This was 
apparently not due to an induction of hepatocyte proliferation but rather a reduction of 
apoptosis in the ligated lobes. Since apoptosis is strongly influenced by the formation of 
porto-portal collaterals, we wanted to investigate collateral formation as reason for the 
reduced suppression of apoptosis, in other words the higher apoptosis rate, in case of the 
20%PHx+70%PVL.  
Formation of extrahepatic porto-portal collaterals was associated with prevention of 
atrophy of deportalized liver. 
The visualization of the portal perfusion immediately after operation indicated that the portal 
vein ligation was well-performed, since no portal perfusion in the portally-ligated lobes was 
visible (data not shown). As expected, the visualization of portal perfusion on POD7 revealed 
that no obvious portal revascularization did occur in the normal liver and between the portal 
stem and the ligated portal branches after 20%PVL and 70%PVL (Figure 5A, B, C). 
Interestingly, 90%PVL seemed to induce extra-hepatic revascularization as indicated by a 
dense network of small collaterals (Figure 5D) and the clearly visible right portal vein tree 
respectively left portal vein tree supplying the LLL and the ML.  However, formation of this 
dense network did not occur after performing a 20%PVL and simultaneous 70%PHx, leaving 
the right portal vein invisible (Figure 5E). However, collaterals between the stem of the 
portal vein and the LLL and the ML with the subsequent perfusion of the respective lobar 
portal vein became clearly visible after performing a 70%PVL and simultaneous 20%PHx 
(Figure 5F).  
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These findings suggest that on the one hand a large PVL can induce formation of collaterals 
and subsequent suppression of hepatic apoptosis. On the other hand, we observed that 
apoptosis can also be suppressed in case of an additional large resection even without 
formation of collaterals.  
Discussion:  
Intrahepatic liver size regulation is gaining attention from basic scientists as well as 
clinicians. 
PHx and PVL have been adopted to treat liver tumors and metastases in clinic. Thus, 
understanding intrahepatic size regulation after liver resection and PVL is of high clinical 
relevance. Techniques to selectively control liver and liver lobe size could provide new 
chances for extended resection operations
19
.  
 
This study explores intrahepatic size regulation using a newly developed surgical model. 
We asked the question how a given liver lobe may regulate its size when subjected to two 
concurrent stimuli of two different strength: Strong regeneration stimulus induced by 
performing a 70% PHx combined with weak atrophy stimulus induced by 20% PVL, 
respectively weak regeneration stimulus induced by 20% PHx combined with strong atrophy 
stimulus induced by 70% PVL. 
We hypothesized that hepatocytes in the liver lobe receiving both signals may undergo either 
proliferation or apoptosis. The net balance would determine liver size in a stimulus dependent 
manner, since the control of proliferation and the regulation of cell death seems to be tightly 
connected
20
.  
Our results were in support of the hypotheses. We observed three phenomena: (1) The strong 
systemic regeneration stimulus counteracting the weak local atrophy stimulus caused an 
increase in liver lobe size. (2) In contrast, the weak regeneration stimulus counteracting the 
strong local atrophy stimulus resulted in a lower extent of liver size decrease. (3) Furthermore, 
the reduced atrophy of the deportalized lobe seemed to be related to the formation of 
extrahepatic collaterals. 
Proliferation: These observations prompted speculations regarding an unknown sensing 
mechanism in the liver governing intrahepatic size regulation. After PHx the portal inflow to 
the remnant liver increases, accompanied by an increased metabolic load imposed on the 
remnant liver. We speculate that hepatocytes may possibly “sense” the metabolic overload, 
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resulting consequently in increased energy demand of the remnant liver. Nakatani described 
already in 1981 that PHx greatly increases demand for energy
21
. A similar study was 
performed by Ngala Kenda and colleagues 
22
. In their study, the decrease in hepatic ATP 
energy charge, reflecting the increased energy demand, has been suggested to account for the 
early events involved in the initiation of DNA synthesis after PHx.  
Apoptosis: Similarly we speculate that lack of nutrients and hormones from portal blood may 
be sensed as atrophy stimulus triggering hepatic apoptosis. It has been reported that the lack 
of insulin from the portal blood may contribute to hepatic apoptosis. The anti-apoptotic 
effects of insulin on normal hepatocytes were shown in vitro and in vivo by Bilodeau and 
colleagues
23
. In their in-vitro experiment, they applied insulin to transforming growth factor-
beta-treated hepatocyte cultures and observed a decrease in apoptosis by 43%. In their  in-
vivo experiment, they applied insulin to the deportalized liver lobe and observed a five-fold 
decrease in the apoptotic index resulting in a higher liver weight of the atrophying liver lobe 
in comparison  to control animals. 
Collaterals: In consequence, the prevention of apoptosis indicated by the reduced apoptosis 
density may be related to formation of collaterals. The presence of extrahepatic collateral 
formation may explain the moderately reduced apoptosis density observed after 90%PVL and 
20%PHx+70%PVL compared to the high apoptosis density observed after 20% and 70%PVL. 
Here apoptosis may have been prevented by the incomplete lack of nutrients. Our results 
demonstrated that extrahepatic collateral formation resembled collateral formation in case of 
extrahepatic portal hypertension
24
. Extrahepatic collateral formation was accompanied by a 
lower level of atrophy in deportalized liver. This indicated that collateral formation is not only 
reducing liver regeneration but also reducing hepatic atrophy.  
 
Autophagy: However, in the absence of collateral formation, another mechanism must cause 
the suppression of apoptosis.  In case of concurrent signals induced by large PHx and small 
PVL, the sustained proliferation in non-ligated as well as the low proliferation in the ligated 
lobe may not be sufficient to meet the metabolic need. We speculated that in this case a 
“rescue”-mechanism might kick in, which reduced hepatic apoptosis. It is well known that 
nutrient deprivation, in other words starvation, is inducing autophagy
25
. Therefore we 
wondered whether nutrient deprivation in the ligated lobe is inducing autophagy thereby 
preventing apoptosis.   
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The liver is essential for the maintenance of nutrients metabolism and energy homeostasis. 
After extended simultaneous PVL+PHx, the small remnant liver may not meet the energy 
demand. Particularly the portally-deprived liver lobe suffering from nutrient deprivation may 
have a reduced metabolic capacity due to starvation. Lack of nutrients may cause amino acid 
deprivation, adenosine triphosphate depletion and endoplasmic reticulum stress and may lead 
to starvation-induced autophagy in the ligated liver lobe
26
.  
Autophagy is a cellular protein degradation process that enables cells to recycle cytoplasmic 
components through degradation within lysosomes
27
.  Autophagy protects tissues and cells 
against various types of cytotoxic stresses by inhibition of cellular apoptosis. Evidence is 
increasing that autophagy can cross-inhibit apoptosis
28
. Apoptosis is suggested to account for 
the atrophy of the portal blood-deprived liver lobes by activation of the mitochondrial and 
death receptor-mediated pathways
29
. Autophagy can also attenuate apoptosis inhibition by the 
extrinsic pathway of apoptosis
30
. 
 
Perspectives 
Although sound and novel findings were observed in the present study, our study calls for 
consequent investigations of the underlying mechanism.  
For further elucidation whether collateral formation is decisive for intrahepatic liver lobe size 
regulation, we propose a complementary experiment of 70%PV-embolization +20%PHx and 
90% PV-embolization. PV-embolization will prevent formation of collaterals, observed in the 
present study, so that it can be used to investigate the role of collateral formation in balancing 
different signals as a controlled study. 
For further elucidation regarding the role of autophagy in intrahepatic size regulation, we 
propose to investigate the autophagic activity in the regenerating and the atrophying lobe as a 
next step.   
In conclusion, in case of concurrent PVL and PHx, the liver adjusted the size of the portally 
deprived lobe by the balance of liver regeneration and liver atrophy stimulus. The size of 
portally-deprived lobes was dependent on the extent of the additional regenerative stimulus. 
However, the additional hepatectomy induced a similar proliferative response of the portally 
ligated lobe, irrespectively of the extent of resection, but modulated apoptosis differently.  
In case of minor PHx, apoptosis was suppressed to a lower extent thereby not leading to 
hypertrophy but to a mild atrophy of the portally deprived lobe. In case of additional major 
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PHx apoptosis was strongly suppressed causing mild hypertrophy of deportalized lobes, even 
in the absence of collateral formation.  
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Supplemental Table 1 
Supplemental Table 1.  Level of surgical stress as indicated by the release of transaminases 
Severit
y 
Surgery 
ALT (IU/L) 
AST (IU/L) 
  POD
1 
POD
2 
POD
3 
POD
7 
POD
1 
POD
2 
POD
3 
POD
7 
Minor 20%PVL 106.8 68.8 52.0 42.8 429.4 129.4 100.6 90.6 
Moderat
e 
70%PVL 611.6  499.6 243.0 62.2 823.8 609.6 300.5 93.2 
 90%PVL 745.0 164.0 257.4 85.6 963.1 274.7 330.0 114.4 
 20%PHx 499.8 131.2 57.4 65.8 692.6 185.9 106.6 69.2 
Major 70%PHx 1225.
8 
260.6 60.8  42.1 1360.
3 
377.6 102.0 73.8 
 90%PHx 1422.
9 
896.7 260.2 72 2565.
2 
1310.
2 
484.0 102.0 
 20%PVL+70%P
Hx 
1383.
4 
334.0 112.6 40.1 1723.
7 
495.0 192.6 83.0 
 70%PVL+20%P
Hx 
934.6 522.9 123.1 49.2 1505.
9 
580.6 167.2 77.6 
AST: alanine aminotransferase; AST: aspartate aminotransferase; Minor: ALT<250 IU/L and AST<500IU/L; 
Moderate: 250IU/L<ALT<750IU/L and 500IU/L<AST<1000IU/L; Major: ALT>750IU/L, AST>1000IU/L; 
Values: mean values. 
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Legends 
Figure 1: Regulation of total liver/body weight ratio after partial hepatectomy (PHx) 
only, portal vein ligation (PVL) only and combined PVL+PHx. (A) The recovery 
time  of total liver /body weight ratio was related to the extent of PHx. It was  restored 
on POD 2 after 20%PHx, whereas it was not fully recovered on POD 7 after 70%PHx 
and 90%PHx (p<0.001). (B) The total liver /body weight ratio did not change after 
20%PVL and 70%PVL. In contrast, it significantly decreased during the first 3 
postoperative days after 90%PVL and recovered thereafter. There was no significant 
difference between 90%PVL and control value on POD 7 (p=0.627). (C) The recovery 
time of total liver /body weight ratio was also related to the extent of PHx. After 
70%PVL+20%PHx the relative total liver weight was fully recovered on POD 3 
(p=0.217). In contrast, the total liver weight after 20%PVL+70%PHx was not fully 
recovered even on POD 7 (p<0.001). 
Figure 2: Liver size regulation of ligated liver lobes after portal vein ligation (PVL) only 
and combined PVL+PHx. The extent of atrophy on POD 7 was related to the extent 
of ligation and the extent of additional resection. (A) The ligated right lobe decreased 
to 34% after 20%PVL, whereas it increased to 140% after 20%PVL+70%PHx 
(p<0.001). (B) The ligated left lateral and median lobes decreased to 26%, and 46% of 
the original volume after 70%PVL and 90%PVL respectively. However, after  the 
combined 70%PVL+20%PHx  size of LLL+MLdecreased only to 75% of the original 
liver mass (p<0.001). (*:p<0.001, #:p<0.05) 
Figure 3: Proliferation index (PI) after partial hepatectomy (PHx) only, portal vein 
ligation (PVL) only and combined PVL+PHx. (A) PI of non-ligated lobes after 
PHx only: After PHx, PI of the remnant liver peaked on POD 1 and reached a 
maximum of 3%, 25% and 28% after 20%PHx, 70%PHx and 90%PHx respectively; 
(B)  PI of non-ligated lobe after PVL only: After 20%PVL the PI remained low 
(<2%) without a defined peak throughout the first three postoperative days. In 
contrast, after 70%PVL the peak of proliferation occured on POD 2 and reached a 
considerable maximal level of about 8%. Furthermore, after 90%PVL, the kinetic of 
proliferation was again different; the peak of proliferation occurred on POD 1 and 
reached a maximum of 12.2%; (C) PI of non-ligated lobes in combination groups: 
In both combination groups, there were no defined peaks of proliferation, but maximal 
PI ranging between 10% and 16% were observed on the first two postoperative days. 
(D) PI of the ligated liver lobes after PVL only respectively in the combination 
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groups: After PVL only, proliferation was absent after small 20% PVL and very low 
after 70% and 90%PVL (maximum PI of 0.3% on POD 2). In contrast, in both 
combination groups where an additional resection was performed, the PI of ligated 
lobe was more than 10-fold higher (4%-6% on POD 2) comparing with PI after PVL 
only. (*:p<0.001, #:p<0.050, NS: not significant).  (E) BrdU-staining of ligated right 
or left lateral lobe (RL or LLL) on POD 2 after 90%PVL, 20%PVL+70%PHx and 
70%PVL+20%PHx (scale marker:100μm, magnification:200×). Despite portal 
deprivation, proliferating cells were clearly visible in the ligated RL after 
20%PVL+70%PHx  respectively the LLL after 70%PVL+20%PHx. 
Figure 4: Density of apoptotic cells in deportalized lobe on POD3. After small to 
moderate PVL only, density of apoptotic cells was high and ranged between 25-35 
cells/mm
2
 in left lateral (20%PVL, A) and right lobe (70% PVL, B). In contrast, after 
large 90% PVL only, density of apoptotic cells was significantly lower in the ligated 
lobes with 5 cells/mm
2
 in RL respectively 14 cells/mm
2
 in LLL (p<0.001); possibly 
due to the formation of collaterals as shown in Figure 5D. In both combination 
groups, density of apoptotic cells was as low as after 90%PVL, and seemed to be 
related to the extent of the additional resection. Density of apoptotic cells was very 
low in the ligated RL with 3 cells/mm
2 
 after  small ligation and large resection 
(20%PVL+70%PHx). However, in this case no collaterals were abserved, see Figure 
5E. Density of apoptotic cells was significantly higher and reached 14 cells/mm
2
 in the 
LLL+ML after large ligation and small resection (70%PVL+20%PHx) (p<0.001).  
Here, collateral formation was clearly visible, see Figure 5F. (C) TUNEL-staining of 
deportalized right lobe (RL, upper panel) after 20%PVL, 20%PVL+70%PHx and 
90%PVL, and TUNEL-staining of deportalized left lateral lobe (LLL, lower panel) 
after 70%PVL, 70%PVL+20%PHx and 90%PVL. After PVL only (left panel), 
abundant apoptotic cells were clearly visible, whereas after the combined procedure, 
only signal TUNEL-positive cells were visible (middle and right panel) (scale 
marker:100µm, magnification:200×) 
Figure 5: Visualization of portal venous tree on POD7. (A) Normal portal venous tree. (B, 
C) After 20%PVL and 70%PVL no collaterals between portal stem and ligated lobar 
portal veins were observed. (D) However, after 90%PVL the ligated liver lobes were 
portally-perfused and extrahepatic portal collateral formation between portal stem and 
lobar portal veins was observed; (E) After 20%PVL+70%PHx the ligated right lobes 
were not portally-perfused indicating there was no formation of collaterals; (F) In 
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contrast, after 70%PVL+20%PHx obvious collateral formation was noticed and the 
ligated liver lobes were portally-perfused. (red arrow indicates collateral; red circle 
indicates portally-ligated lobe; orange rectangle indicates resected liver lobes) 
 
Legends for Supplemental Figures 
Supplemental Figure 1: Sketches of experimental groups. (red cross: portal vein ligation; grey 
colored lobes: deportalized lobes; orange colored lobes: portalized lobes)  
Supplemental Figure 2: Intraoperative images after combined portal vein ligation (PVL) 
and partial hepatectomy (PHx) of different extent (A, C) and images of explanted 
livers on POD 7 to illustrate liver lobe size adjustment (B, D). (A) Intraoperative 
situs after 20%PVL+70%PHx:  depicting portally deprived right lobes (black 
arrows) with darker red color after PVL (black cross) and stumps of left lateral and 
median lobes (white  circle) after resection, and remnant caudate lobes with fresh red 
color (white arrow);(B) Explanted liver after 20%PVL+70%PH on POD7: 
demonstrating the discrete hypertrophy of the deportalized right lobe (black arrows) 
and the substantial 4-fold increase in size of the regenerating caudate lobes (white 
arrows); (C) Intraoperative situs after 70%PVL+20%PHx: depicting portally 
deprived left lateral and median lobes (black arrows) with darker red color after PVL 
(black cross) and stumps of right lobes (white circle), and remnant caudate lobes with 
fresh red color (white arrow); (D) Explanted liver after 70%PVL+20%PHx on 
POD7: demonstrating discrete atrophy of left lateral and median lobes (black 
arrows) and the substantial 4-fold increase in size of the regenerating caudate lobes 
(white arrows)  
Supplemental Figure 3: Size regulation of portalized caudate lobe (A) At all observation 
time points the relative weight of portalized lobe was significantly higher after both 
combined procedures compared to 90%PVL only. (B) Proliferation index (PI) 
ranging between 13% and16% was observed on POD 1 in all three groups  (p>0.050). 
Thereafter (POD 2 and 3), the PI in both combination groups remained significantly 
higher as after 90%PVL only,  (p<0.001). Both observations together suggest an 
increased regenerative response in case of the additional resection.  (*:p<0.001, 
#:p<0.05). (C) BrdU-staining of non-ligated caudate lobe (CL) on POD2 after 
20%PVL+70%PHx, 70%PVL+20%PHx and 90%PVL. Density of Brdu-marked 
proliferating cells in both combination groups (left and middle image) much higher 
than after 90%PVL only (right image). (scale marker:100μm, magnification:200×). 
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Discussion 
Liver regeneration has been and is being studied using various experimental models.  
Partial hepatectomy (PHx) is the most frequently used surgical model to study liver 
regeneration. The small liver remnant undergoes full volume and functional regeneration 
within 7-14 days. However, in clinical routine, extended liver resection is not always 
possible due to a presumingly insufficient size of the future liver remnant. Therefore, PVL 
was developed to enhance regeneration prior to extended resection.  
However, this concept does not always lead to success; the future liver remnant does not 
always undergo sufficient volume and functional regeneration. Up to now, it is not well 
explored how liver regeneration is regulated, especially not how the individual liver lobes 
adjust their size after resection or portal vein ligation. Further research is needed to better 
understand this process of intrahepatic size regulation.  
We investigated two interrelated factors influencing intrahepatic size regulation: the effect 
of vascular remodeling in terms of collateral formation and the effect of simultaneously 
applied concurrent signals.   
First we gained an overview about current techniques to explore liver regeneration, 
especially the imaging techniques to demonstrate the hepatic vascular system (Manuscript 
I, published). We generated an ALPPS model and confirmed that prevention of collateral 
formation by parenchymal transection accelerated liver regeneration (Manuscript II, 
published). We observed that the PHx induced regeneration stimulus prevented hepatic 
atrophy of deportalized liver lobe by inducing hepatocyte proliferation (Manuscript III, 
published). We learned that inhibition of atrophy in the deportalized liver lobe was 
associated with down-regulation of hepatic apoptosis, which was inversely correlated to 
the strength of the regenerative stimulus induced by PHx (Manuscript IV, submitted).  
Modern technologies enable visualization of collaterals 
Contrasting the vascular tree was achieved by injecting a silicone radiopaque contrast 
agent (Microfil; Flow Tech, Inc.) into the portal vein. The explanted liver was subjected to 
Micro-CT (TomoScope Duo CT; CT Imaging GmbH). The data from micro-CT was 
subjected to 3D reconstruction using “Imalytics preclinic” (Philips Research) and 
“HepaVison” (Fraunhofer Institute for Medical Image Computing MEVIS).  
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Both programs allow the visualization of the topographic vascular anatomy of the liver. 
Imalytics preclinic and HepaVision enable free rotation of the vascular tree and optimal 
demonstration of the intrahepatic and extrahepatic collateral formation after PVL. In 
addition, HepaVison allows determination of hepatic volume and volume of territories of 
lobes, visualization of collaterals and determination of vascular parameter and therefore 
vascular growth in liver regeneration (Xie et al. 2016). 
However, there are still limitations when using the imaging technologies: one being  the 
low resolution of the µCT imaging device (70µm) which renders visualization of very 
small vessels like the sinusoidal network of the remnant liver impossible; the other being 
the need for applying the silicone polymer for contrasting the vessels. This contrast 
medium crystallizes in the vessels and can only be used in explanted livers, rendering the 
repetitive imaging of the vascular tree within the same animal impossible.  
Development of novel contrast media allowing in-vivo imaging of the rat liver at high 
resolution is needed to overcome these limitations. 
Role of collaterals in size regulation: Prevention of collateral formation accelerates 
liver regeneration  
Formation of interlobe porto-portal neocollaterals after PVL is considered to be one of 
major factors reducing the extent of hypertrophy in the FLR (Riehle et al. 2011). This 
prompted the development of the ALPPS-procedure to prevent the formation of porto-
portal collaterals. The key step of this procedure is the trans-section of hepatic 
parenchyma after ligating the portal vein. Prevention of PV-collateralization is achieved 
by placing a mechanical barrier between the transected liver lobes (Tanaka et al. 2015).  
In addition to preventing formation of collaterals, liver transection also causes a traumatic 
stimulus, which may contribute to the accelerated hypertrophy of FLR (Gall et al. 2015). 
Schlegel came up with the speculation of a circulating growth factor induced by surgical 
injury. In their study, surgical injuries to spleen, kidney or lung induced comparable liver 
regeneration after PVL like ALPPS (Schlegel et al. 2014). The authors therefore 
concluded that a systemic growth factor rather than preventing the formation of porto-
portal collaterals was essential for the observed accelerated liver regeneration after 
ALPPS. Unfortunately, they did not investigate size development of the deportalized lobe 
after ALPPS procedure.  
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Our study questioned this point of view. It seems unlikely that the postulated systemic 
growth factor induces accelerated hypertrophy of the portalized lobe and augmented 
atrophy of deportalized lobe at the same time. In our study, prevention of porto-portal 
collateral formation after ALPPS led to enhanced hypertrophy of FLR and enhanced 
atrophy of the ligated lobe compared to that after PVL without liver transection. Our study 
did not address the role of eventual systemic growth factors. However, the key role of 
preventing collateral formation cannot be denied.  
 
It is also tempting to consider the controversially discussed role of hypoxia for accelerated 
regeneration. On the one hand, hypoxia after PVL is considered to act as stimulus for 
regeneration. On the other hand, increasing oxygen supply via arterialization of PV after 
hepatectomy is apparently enhancing regeneration.  
In ALPPS model with 70%PVL, the parenchymal transection prevents collateral 
formation between portalized lobe and deportalized lobe leading to hyperperfusion of the 
regenerating lobe. In response to portal hyperperfusion, hepatic arterial flow to the 
regenerating lobe should decrease accordingly to maintain the constant hepatic sinusoidal 
inflow (Lautt 2007, Lautt 1985). Schadde observed that the decreased arterial flow was 
causing hypoxia (indicated by pimonidazole staining) in the regenerating liver; the 
hypoxia subsequently accelerated liver regeneration after portal deprivation (Schadde et al. 
2016). The observation of Kron supported this view (Kron et al. 2016). He observed 
significant hypoxia during liver regeneration, also indicated by Pimonidazol staining. 
They further demonstrated that hypoxia-driven Hif2a activation promoted hepatocytes 
mitosis.  
In contrast to these observations, other studies suggest that the reduced oxygen supply 
would be detrimental to liver regeneration, albeit after 70%PHx (Eipel et al. 2010). Nardo 
reported that portal vein arterialization increased O2 partial pressure and oxygen 
saturation in the portal vein and enhanced the BrdU-proliferation rate by 3-fold.  (Nardo et 
al. 2006). Li also demonstrated that portal vein arterialization promoted liver regeneration 
after extended hepatectomy in a rat model (Li et al. 2015).  
This debate requires further experiments to define the role of oxygen and hypoxia for 
accelerating or decreasing live regeneration, possibly by exploring the role of portal vein 
arterialization in intrahepatic size regulation after the ALPPS procedure. These 
experiments would improve our understanding of liver regeneration and contribute to the 
optimized performance of ALPPS.  
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Regeneration stimulus prevents the hepatic atrophy of deportalized liver lobe by 
inducing hepatocyte proliferation.  
Portal vein blood is considered to be essential for liver regeneration (van Lienden et al. 
2013). Currently two mechanisms regarding the relevance of portal vein blood are 
discussed. The hemodynamic theory suggests that the increased portal blood flow 
resulting in an elevated shear stress is the driving force for liver regeneration after PHx 
and PVL (Um et al. 1994, Schoen et al. 2001). Furthermore, PHx and portal vein 
occlusion results to metabolic overload as well as an increased hormonal supply from the 
gut to the non-deprived remnant liver lobe, both leading to the hypertrophy of the 
portalized lobe (Wilms et al. 2008). However, our study regarding intrahepatic size 
regulation rejects the essential role of portal inflow for liver regeneration.  
Our results demonstrated that liver regeneration can be induced in portally-deprived liver 
lobes within the first week, albeit following a different kinetics. This was in line with 
Kollmar’s finding. He also observed cell proliferation in the portal blood-deprived liver 
tissue, but only in the late phase. In his study the expression of PCNA was detected on day 
14 after PVL (Kollmar et al. 2007).  
 
Without any evidence of porto-portal collateral formation, we could speculate about the 
role of arterial flow to the deprived lobe in priming hepatocyte proliferation.  
Portal hypertension after PHx is considered to reduce hepatic arterial inflow to the 
remnant liver because of the hepatic arterial buffer response (HABR), described by Lautt 
in 1985 (Lautt 1985). A controversial finding has been reported by Dold who observed 
that portal hyperperfusion after PHx (30%, 70% and 90%PHx) did not induce an adaptive 
hepatic arterial constriction because of nitric oxide release (Dold et al. 2015). However, 
the author also emphasized that “the lack of HABR after major hepatectomy despite portal 
hyperperfusion may not necessarily disprove the HABR theory”. The nitric oxide release 
may counteract the HABR by dilating the hepatic artery (Macedo und Lautt 1998). 
The HABR was also investigated after 70%PVL (Gock et al. 2011). Gock reported an 
unchanged sinusoidal blood flow in the sinusoids, although the liver underwent portal 
deprivation. This observation implied an elevated arterial inflow to the deportalized lobes. 
Applying those studies to the analysis of our observations, one might speculate that 
arterial inflow to the deprived right lobes may increase massively because of the 
additional liver resection. However, we did not yet provide experimental evidence. The 
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increased arterial flow due to the additional resection may cause a substantially elevated 
shear stress, possibly triggering liver regeneration, even in the deportalized lobe.  
However, liver regeneration followed a different time course with a delayed peak 
occurring only at 48h. The prolonged course of regeneration in the portally deprived liver 
lobe is possibly related to the lack of nutrients normally supplied by the portal blood, 
needed to meet the energy demand of the proliferating hepatocytes.  
Further elucidation of the underlying mechanism would call for additional experiments 
with a detailed examination if hepatic hemodynamics on the level of the remnant liver, but 
also on the level of the lobar vessels. However, this is technically currently unfeasible due 
to the lack of required very small sensors to measure lobar inflow directly (Schadde et al. 
2016). 
 
The regenerative stimulus governs the size regulation of the deportalized liver by 
determining hepatic apoptosis. 
PHx induces hepatocyte proliferation leading to hypertrophy the liver remnant, whereas 
PVL-induced apoptosis leads to atrophy of the deportalized liver (Zhou et al. 2015). The 
control of cell proliferation and the regulation of cell death are tightly connected 
(Lauschke et al. 2016). We wondered how size regulation was affected when applying the 
two concurrent stimuli of varying strength.  
Our study results revealed that the net balance of the two stimuli determined liver lobe 
size and directed the lobe to undergo either hypertrophy or atrophy or to keep its size. The 
strong systemic regeneration stimulus counteracted the local atrophy stimulus strongly 
leading to an increase in liver lobe size. In contrast, the moderate regeneration stimulus 
counteracted against the local atrophy stimulus only moderately leading to a lower 
decrease of liver size compared to PVL only. 
 
We reported as key finding that hepatic apoptosis was dramatically reduced in the 
deportalized lobe, when it was subjected to an additional liver resection representing a 
regeneration stimulus. Extent of reduction was related to the resected liver mass, in other 
words to the “strength” of the regeneration stimulus. This may be essential for the size 
regulation of the deportalized lobes and important for intrahepatic size regulation of the 
whole liver.  
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Our study revealed that the hepatic apoptosis seemed to be counteracted by extrahepatic 
collateral formation. Our results demonstrated that the extrahepatic collateral formation 
was similar to collateral formation during portal hypertension (Sharma und Rameshbabu 
2012, Kamel et al. 2004). It was noteworthy that the formation of collaterals was 
accompanied by a lower level of atrophy in deportalized liver when compared to the 
situation without collateral formation. This indicated that collateral formation was 
determining hepatic atrophy also in this situation, possibly due to suppression of hepatic 
apoptosis. Collateral formation could contribute to redistribution of hepatic inflow blood 
after PVL. Redistribution of blood flow may normalize the nutrient distribution and 
oxidative homeostasis in the deprived lobe leading to a partial restoration of metabolic 
capacity and modulating apoptosis related pathway (mitochondrial and death receptor-
mediated pathways) (Lee et al. 1999).  
For further elucidation whether the extrahepatic collateral formation is decisive for 
intrahepatic liver lobe size regulation, we propose a complementary experiment of 70% 
portal vein embolization (PVE) combined with 20%PHx, respectively a 90% PVE. PVE 
will prevent formation of intra- and extrahepatic collateral formation, so that it can be 
used to investigate the role of collateral formation in balancing different signals as a 
controlled study. 
 
However, when performing small ligation together with a large resection, we did not 
observe collateral formation. In this case we speculated that another mechanism must be 
responsible for the observed reduction in apoptosis. In the case of concurrent signals 
induced by large PHx and small PVL, the sustained proliferation in non-ligated as well as 
the low proliferation in the ligated lobe may not be sufficient to meet the metabolic need. 
Particularly the portally-deprived liver lobe suffering from nutrient deprivation may have 
a reduced metabolic capacity, partly due to the lack of nutrients provided by the portal 
blood leading to starvation. Nutrient starvation may cause amino acid deprivation, ATP 
depletion and endoplasmic reticulum stress and may lead to starvation-induced autophagy 
in the deprived liver lobe. Evidence is increasing that autophagy influences recycling of 
mitochondria and can thus modulate hepatic apoptosis in mitochondrial pathway (Wang 
2014). Autophagy can also attenuate apoptosis by selectively reducing cytoplasmic pro-
apoptotic proteins in death receptor-mediated pathways (Marino et al. 2014). 
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For further elucidation regarding the role of autophagy in intrahepatic size regulation, we 
propose to investigate the autophagic activity in the regenerating and the atrophying lobe 
as a next step. 
 
In conclusion, our studies provide novel and interesting surgical findings regarding 
intrahepatic size regulation. Our results challenge the widely assumed paradigm that 
portal deprivation leads to hepatic atrophy and prevents liver regeneration. Further work is 
needed to understand the underlying molecular mechanisms.  
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